Simone Seiter
Saarland University
19 Papers
217 Citations
Simone Seiter is an academic researcher from Saarland University. The author has contributed to research in topics: Melanoma & Cytokine. The author has an hindex of 13, co-authored 19 publications. Previous affiliations of Simone Seiter include University Hospital Heidelberg.
Chat about Author
Papers
High-Dose Pulse Corticosteroid Therapy in the Treatment of Severe Alopecia areata
TL;DR: In patients with AA plurifocalis, higher response rates could be observed in those suffering from long-term disease compared to patients treated during their first episodes of AA, and high-dose methylprednisolone pulse therapy might be less beneficial for patients with ophiasic AA, AA totalis or universalis.
67
Heterogenous susceptibility to CD95‐induced apoptosis in melanoma cells correlates with bcl‐2 and bcl‐x expression and is sensitive to modulation by interferon‐γ
TL;DR: IFN‐γ, but not IFN‐α, is able to increase the susceptibility of sensitive cell lines and to induce CD95 sensitivity in resistant melanoma cell lines, accompanied by up‐regulation of the protein expression level of CD95 and/or bcl‐xS.
64
Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.
TL;DR: In this paper, the authors evaluated the effectiveness of intravenous methylprednisolone (8mg/kg body weight) administered on three consecutive days in patients with generalized vitiligo.
49
Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: An open pilot study in 3 patients
TL;DR: The results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP, which is mostly resistant to other treatment modalities.
46
•Journal Article
Efficacy of Local versus Systemic Application of Antibody-Cytokine Fusion Proteins in Tumor Therapy
TL;DR: In mice bearing a human epidermal growth factor receptor-positive melanoma transplant and being reconstituted with human HLA-matched peripheral blood leukocytes, the efficacy of both IL2- FuP and TNF-FuP depended on the induction of an immune response in vivo and the therapeutic effect was improved by intratumoral application.
38